Physician profile
Skyler Jay Smith
NPI 1811489594
$4,538.82
in general payments reported to CMS, 2019-2025
11 companies · $791 in 2025
The $791 reported for 2025 was more than what 94% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $780 · 2022: $1,380 · 2023: $95.88 · 2024: $1,492 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,676 · Food and Beverage: $703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,676.04 |
| Food and Beverage | $702.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $1,600.60 | 2024-2025 | |
| Dentsply Sirona INC | $1,518.47 | 2021-2025 | Lucitone, Astra Tech Implant System, Implant Dentistry |
| Hu-Friedy Mfg. Co., LLC | $447.30 | 2022 | |
| Zimmer Biomet Holdings, INC. | $419.96 | 2021 | |
| A-Dec, INC. | $300.00 | 2021 | |
| Ultradent Products INC | $66.88 | 2024 | |
| Metrex Research, LLC | $47.94 | 2023 | Eyezoom |
| Nobel Biocare USA | $47.94 | 2023 | Nobelactive |
| Straumann USA LLC | $33.60 | 2021 | |
| Kulzer, LLC | $31.47 | 2024 | |
| Biohorizons Implant Systems INC. | $24.66 | 2024 | Biohorizons |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Skyler Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.